Lung cancer staging and prognosis
GA Woodard, KD Jones, DM Jablons - Lung cancer: treatment and …, 2016 - Springer
The seventh edition of the non-small cell lung cancer (NSCLC) TNM staging system was
developed by the International Association for the Staging of Lung Cancer (IASLC) Lung …
developed by the International Association for the Staging of Lung Cancer (IASLC) Lung …
[HTML][HTML] Recurrence after surgery in patients with NSCLC
H Uramoto, F Tanaka - Translational lung cancer research, 2014 - ncbi.nlm.nih.gov
Surgery remains the only potentially curative modality for early-stage non-small cell lung
cancer (NSCLC) patients and tissue availability is made possible. However, a proportion of …
cancer (NSCLC) patients and tissue availability is made possible. However, a proportion of …
Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non–small cell lung cancer
Importance The prevalence of early-stage non–small cell lung cancer (NSCLC) is expected
to increase with recent implementation of annual screening programs. Reliable prognostic …
to increase with recent implementation of annual screening programs. Reliable prognostic …
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
LJ Esserman, IM Thompson, B Reid, P Nelson… - The lancet …, 2014 - thelancet.com
A vast range of disorders—from indolent to fast-growing lesions—are labelled as cancer.
Therefore, we believe that several changes should be made to the approach to cancer …
Therefore, we believe that several changes should be made to the approach to cancer …
Updated prognostic factors in localized NSCLC
Simple Summary In resected lung cancer, adjuvant and neoadjuvant chemotherapy
following surgery are currently mainly based on TNM classification. With the validation and …
following surgery are currently mainly based on TNM classification. With the validation and …
Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma
Two CT features were developed to quantitatively describe lung adenocarcinomas by
scoring tumor shape complexity (feature 1: convexity) and intratumor density variation …
scoring tumor shape complexity (feature 1: convexity) and intratumor density variation …
Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy
F Ulloa-Montoya, J Louahed, B Dizier… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To detect a pretreatment gene expression signature (GS) predictive of response to
MAGE-A3 immunotherapeutic in patients with metastatic melanoma and to investigate its …
MAGE-A3 immunotherapeutic in patients with metastatic melanoma and to investigate its …
[HTML][HTML] Validation of a histology-independent prognostic gene signature for early-stage, non–small-cell lung cancer including stage IA patients
SD Der, J Sykes, M Pintilie, CQ Zhu, D Strumpf… - Journal of thoracic …, 2014 - Elsevier
Background: Patients with early-stage non–small-cell lung carcinoma (NSCLC) may benefit
from treatments based on more accurate prognosis. A 15-gene prognostic classifier for …
from treatments based on more accurate prognosis. A 15-gene prognostic classifier for …
Biomarker discovery in non–small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation
J Botling, K Edlund, M Lohr, B Hellwig, L Holmberg… - Clinical cancer …, 2013 - AACR
Purpose: Global gene expression profiling has been widely used in lung cancer research to
identify clinically relevant molecular subtypes as well as to predict prognosis and therapy …
identify clinically relevant molecular subtypes as well as to predict prognosis and therapy …
Big data in basic and translational cancer research
Historically, the primary focus of cancer research has been molecular and clinical studies of
a few essential pathways and genes. Recent years have seen the rapid accumulation of …
a few essential pathways and genes. Recent years have seen the rapid accumulation of …